Fructo-oligosaccharides
Also known as: FOS, fructooligosaccharides, inulin-type fructans (short-chain)
Systematic reviews and meta-analyses of human trials show that oral FOS reliably increase Bifidobacterium abundance, with larger effects at doses >5 g/day and with interventions >4 weeks. Trials and reviews report associated changes in short-chain fatty acids and some signals for improved laxation, mineral uptake and lipid or glucose parameters, while gastrointestinal symptoms such as bloating and flatulence are reported but not consistently increased versus control.
Last reviewed: 2026-10-14 · 5 indexed studies
Set your location for accurate regulatory status
Saved on this device — no sign-in needed.
Overview
Fructo-oligosaccharides (FOS) are short-chain inulin-type fructans used as prebiotic fibres. Human trials and meta-analyses report that FOS increase bifidobacteria and can modify gut microbiota composition, with some evidence for benefits in laxation, mineral absorption and aspects of metabolic health.
Mechanism & Function
Mechanism of Action
FOS are non-digestible fermentable fibres selectively utilised by beneficial gut microbes (notably Bifidobacterium), leading to production of short-chain fatty acids and downstream effects on intestinal barrier function, mineral solubility/absorption and metabolic signalling.
Physiological Role
Serve as a fermentable substrate for saccharolytic gut bacteria, promote growth of commensal genera (Bifidobacterium, Lactobacillus), and increase production of short-chain fatty acids such as acetate.
Primary Pathways
Performance / Health Relevance
Primarily relevant to gut health, bowel regularity and broader metabolic/endocrine signalling mediated via microbiota and SCFA production rather than direct ergogenic effects.
Evidence Review
Practical Use & Dosage
- Minimum Effective Dose
- Around 5 g/day (meta-analysis subgroup effects were larger >5 g)
- Optimal Range
- Approximately 5–15 g/day based on doses reported in trials and maternal RCT (14.2 g/day)
- Upper / Caution Level
- Not established; higher fermentable fibre doses may increase bloating and flatulence
- Timing
- No specific timing established; typically taken daily mixed into food or drink
- Best Format
- Powder (mixed into food/drink) or included in synbiotic formulations
- Bioavailability
- Not systemically absorbed; effects depend on colonic fermentation and microbiota composition
- Absorption Considerations
- Fermented by colonic bacteria; rapid fermentation can cause gas and bloating in some individuals
Safety & Interactions
Side Effects
- •Bloating
- •Flatulence
- •Increased gas
- •Possible transient abdominal discomfort
Who Should Avoid
- •Individuals with known severe gastrointestinal motility disorders or severe small intestinal bacterial overgrowth (no direct trial evidence)
Monitoring
Monitor tolerance (gas, bloating) when initiating or increasing dose; adjust dose if symptoms occur.
Frequently Asked Questions
Auto-generated from indexed evidence — dosage, safety, interactions, and more.
When is Fructo-oligosaccharides typically used or indicated?
Fructo-oligosaccharides is most commonly used for: Prebiotic for gut microbiota modulation, Improve bowel function, Adjunct to maternal supplementation in pregnancy/lactation, Support mineral absorption and lipid profile. Serve as a fermentable substrate for saccharolytic gut bacteria, promote growth of commensal genera (Bifidobacterium, Lactobacillus), and increase production of short-chain fatty acids such as acetate.
How does Fructo-oligosaccharides work?
FOS are non-digestible fermentable fibres selectively utilised by beneficial gut microbes (notably Bifidobacterium), leading to production of short-chain fatty acids and downstream effects on intestinal barrier function, mineral solubility/absorption and metabolic signalling.
What is the recommended dose of Fructo-oligosaccharides?
The optimal range is Approximately 5–15 g/day based on doses reported in trials and maternal RCT (14.2 g/day). with a minimum effective dose of Around 5 g/day (meta-analysis subgroup effects were larger >5 g). Best taken: No specific timing established; typically taken daily mixed into food or drink. Upper / caution level: Not established; higher fermentable fibre doses may increase bloating and flatulence.
What are the side effects of Fructo-oligosaccharides?
Reported side effects include: Bloating; Flatulence; Increased gas; and Possible transient abdominal discomfort. Monitoring: Monitor tolerance (gas, bloating) when initiating or increasing dose; adjust dose if symptoms occur.
Who should avoid Fructo-oligosaccharides?
Fructo-oligosaccharides is generally not recommended for: Individuals with known severe gastrointestinal motility disorders or severe small intestinal bacterial overgrowth (no direct trial evidence).
How strong is the evidence for Fructo-oligosaccharides?
Evidence level: Moderate (overall score 72/100), based on 5 indexed studies on SuppIndex.
Research & References (5)
The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review.
Systematic review of inulin-type fructans (including short-chain FOS) in healthy adults examining microbiota and extraintestinal outcomes.
Effect of Fructooligosaccharides Supplementation on the Gut Microbiota in Human: A Systematic Review and Meta-Analysis.
Meta-analysis of randomized controlled trials assessing FOS supplementation effects on gut microbiota and gastrointestinal symptoms.
The Impact of Probiotics, Prebiotics, and Synbiotics during Pregnancy or Lactation on the Intestinal Microbiota of Children Born by Cesarean Section: A Systematic Review.
Systematic review of probiotic, prebiotic and synbiotic use during pregnancy/lactation to alter infant microbiota in cesarean-delivered newborns; included synbiotics containing FOS.
Prebiotics for people with cystic fibrosis.
Cochrane-style systematic review searching for RCTs of prebiotics (including FOS) in people with cystic fibrosis.
Maternal prebiotic supplementation during pregnancy and lactation modifies the microbiome and short chain fatty acid profile of both mother and infant.
Randomised, double-blind, placebo-controlled trial of maternal supplementation with GOS/FOS (9:1) from <21 weeks' gestation to six months postpartum assessing maternal and infant microbiota and stool SCFA.
Related Ingredients
Other top-rated ingredients in General Health Ingredients.
Piperine
82/100A piperidine alkaloid (C₁₇H₁₉NO₃) that inhibits cytochrome P450 enzymes (CYP3A4, CYP1A2, CYP2E1), P-glycoprotein efflux transporters, and UDP-glucuronosyltransferases while enhancing intestinal permeability, digestive enzyme secretion, and splanchnic blood flow — collectively producing dramatic improvements in nutrient bioavailability.
CoQ10
78/100Endogenous lipid-soluble ubiquinone/ubiquinol that shuttles electrons in the mitochondrial respiratory chain and acts as a membrane antioxidant.
Beta-Glucan (Oat)
77/100Multiple randomized trials and meta-analyses report that ≥3 g/day oat beta-glucan lowers LDL and total cholesterol modestly. Acute feeding trials pooled in meta-analysis show dose- and molecular-weight–dependent reductions in postprandial glucose and insulin responses.
Research Overview
Moderate EvidenceCite this ingredient
One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.
Stable URL
https://thesuppindex.com/ingredients/fructo-oligosaccharides
SuppIndex. (2026). Fructo-oligosaccharides: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/fructo-oligosaccharides
Based on 5 indexed studies · Evidence level: Moderate.
Goal Ratings
Stack Compatibility
Commonly used together with probiotic strains (synbiotics) and galacto-oligosaccharides in trials; combination may be used to enhance bifidogenic effects.